版本:
中国

BRIEF-BioPharmX completes last subject visit in its phase 2B trial of BPX-01, expects to report topline results first half of May

April 20 BioPharmX Corp

* BioPharmX completes last subject visit in its phase 2B trial of BPX-01, expects to report topline results first half of May 2017

* BioPharmX Corp- Expects to report topline results first half of May 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐